Global Information
회사소개 | 문의

세계의 오소바이오로직스 시장 예측(-2022년) : 관절내 점성보충, 합성 오소바이오로직스, 탈회골기질(DBM), 골형성단백질(BMP), 자가골수 줄기세포(BMAC)

Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC, Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft Tissue), End User - Global Forecast to 2022

리서치사 MarketsandMarkets
발행일 2017년 09월 상품 코드 560771
페이지 정보 영문 158 Pages
가격
US $ 5,650 ₩ 6,460,200 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,650 ₩ 7,603,600 PDF by E-mail (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,150 ₩ 9,318,700 PDF by E-mail (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없지만, 동일 국가의 동일 사업장에 한정되며 해외지점 등은 포함되지 않습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,000 ₩ 11,434,000 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 오소바이오로직스 시장 예측(-2022년) : 관절내 점성보충, 합성 오소바이오로직스, 탈회골기질(DBM), 골형성단백질(BMP), 자가골수 줄기세포(BMAC) Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC, Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft Tissue), End User - Global Forecast to 2022
발행일 : 2017년 09월 페이지 정보 : 영문 158 Pages

한글목차

세계의 오소바이오로직스 시장은 5.4%의 연평균 성장률(CAGR)로 성장하여 2017년 46억 6,000만 달러에서 2022년에는 60억 6,000만 달러로 확대될 전망입니다. 정형외과 손상의 부담 확대, 스포츠에 의한 부상과 교통사고 발생률 증가, 척추 고정 수술수 증가, 고령자 인구·비만율·근골격 장애의 증가에 관련된 위험인자, 환자의 최소침습성 시술에 대한 선호도 고조는 오소바이오로직스 시장 성장을 촉진하고 있습니다. 그러나 오소바이오로직스 기반 치료와 관련된 고비용은 시장 성장을 어느 정도 저해하는 주요 요인입니다.

세계의 오소바이오로직스(Orthobiologics) 시장에 대해 조사 분석했으며, 시장 개요, 산업 동향, 부문별 시장 분석, 경쟁 구도, 주요 기업 등의 정보를 전해드립니다.

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 주요 조사 결과

  • 세계의 오소바이오로직스 시장 개요
  • 세계의 오소바이오로직스 시장 : 제품별
  • 오소바이오로직스 시장 : 지역 분석
  • 오소바이오로직스 시장 : 용도별
  • 세계의 오소바이오로직스 시장 규모 : 최종사용자별

제5장 시장 개요

  • 서론
  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 기회
    • 해결해야 할 과제
  • 주요 산업 동향

제6장 오소바이오로직스 시장 : 제품별

  • 서론
  • 관절내 점성보충 제품
  • 탈회골기질(DBM)
  • 합성 오소바이오로직스
  • 골형성단백질(BMP)
  • 동종이식편
  • 혈장 풍부 단백질
  • 자가골수 줄기세포(BMAC)

제7장 오소바이오로직스 시장 : 용도별

  • 서론
  • 골관절염
  • 척추 고정술
  • 연골 손상
  • 골절 회복
  • 악안면 및 치과 용도

제8장 오소바이오로직스 시장 : 최종사용자별

  • 서론
  • 병원, 정형외과 및 외래 진료 센터
  • 연구 및 대학 기관
  • 치과 및 시설

제9장 오소바이오로직스 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양(APAC)
  • 기타

제10장 경쟁 구도

  • 시장 순위

제11장 기업 개요

  • DEPUY SYNTHES(A SUBSIDIARY OF JOHNSON & JOHNSON)
  • MEDTRONIC PLC.
  • STRYKER CORPORATION
  • ZIMMER BIOMET HOLDINGS, INC.
  • HARVEST TECHNOLOGIES CORPORATION(A TERUMO BCT COMPANY)
  • GLOBUS MEDICAL, INC.
  • ORTHOFIX INTERNATIONAL N.V.
  • RTI SURGICAL, INC.
  • K2M GROUP HOLDINGS, INC.
  • KUROS BIOSCIENCES LTD.
  • BIOVENTUS LLC
  • NUVASIVE, INC.
  • SEASPINE HOLDINGS CORPORATION
  • ARTHREX, INC.
  • XTANT MEDICAL HOLDINGS, INC.

제12장 부록

KSM 17.10.16

LIST OF TABLES

  • TABLE 1: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 2: ORTHOBIOLOGICS MARKET FOR VISCOSUPPLEMENTATION PRODUCTS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 3: ORTHOBIOLOGICS MARKET FOR DEMINERALIZED BONE MATRICES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 4: ORTHOBIOLOGICS MARKET FOR SYNTHETIC ORTHOBIOLOGICS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 5: ORTHOBIOLOGICS MARKET FOR BONE MORPHOGENIC PROTEIN, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: ORTHOBIOLOGICS MARKET FOR ALLOGRAFTS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: ORTHOBIOLOGICS MARKET FOR PLASMA-RICH PROTEIN, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: ORTHOBIOLOGICS MARKET FOR BONE MARROW ASPIRATE CONCENTRATE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 10: ORTHOBIOLOGICS MARKET FOR OSTEOARTHRITIS AND DEGENERATIVE ARTHRITIS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: ORTHOBIOLOGICS MARKET FOR SPINAL FUSION, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: ORTHOBIOLOGICS MARKET FOR SOFT-TISSUE INJURIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: ORTHOBIOLOGICS MARKET FOR FRACTURE RECOVERY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: ORTHOBIOLOGICS MARKET FOR MAXILLOFACIAL AND DENTAL APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: GLOBAL ORTHOBIOLOGICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 16: GLOBAL ORTHOBIOLOGICS MARKET FOR HOSPITALS, ORTHOPEDIC CLINICS, AND AMBULATORY CARE CENTERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: GLOBAL ORTHOBIOLOGICS MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: GLOBAL ORTHOBIOLOGICS MARKET FOR DENTAL CLINICS AND FACILITIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: ORTHOBIOLOGICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: ORTHOBIOLOGICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 21: NORTH AMERICA: ORTHOBIOLOGICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 22: NORTH AMERICA: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 23: NORTH AMERICA: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 24: NORTH AMERICA: ORTHOBIOLOGICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 25: US: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 26: US: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 27: CANADA: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 28: CANADA: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 29: EUROPE: ORTHOBIOLOGICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 30: EUROPE: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 31: EUROPE: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 32: EUROPE: ORTHOBIOLOGICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 33: GERMANY: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 34: GERMANY: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 35: FRANCE: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 36: FRANCE: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 37: UK: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 38: UK: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 39: SPAIN: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 40: SPAIN: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 41: ITALY: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 42: ITALY: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 43: ROE: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 44: ROE: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 45: ASIA PACIFIC: ORTHOBIOLOGICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 46: ASIA PACIFIC: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 47: ASIA PACIFIC: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 48: ASIA PACIFIC: ORTHOBIOLOGICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 49: JAPAN: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 50: JAPAN: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 51: CHINA: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 52: CHINA: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 53: INDIA: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 54: INDIA: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 55: ROAPAC: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 56: ROAPAC: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 57: ROW: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 58: ROW: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 59: ROW: ORTHOBIOLOGICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 60: GLOBAL ORTHOBIOLOGICS MARKET RANKING, BY KEY PLAYERS, 2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 3: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 4: BREAKDOWN OF PRIMARIES
  • FIGURE 5: BOTTOM-UP APPROACH
  • FIGURE 6: TOP-DOWN APPROACH
  • FIGURE 7: DATA TRIANGULATION
  • FIGURE 8: ASSUMPTIONS OF THE RESEARCH STUDY
  • FIGURE 9: ORTHOBIOLOGICS MARKET, BY TYPE, 2017 VS. 2022
  • FIGURE 10: ORTHOBIOLOGICS MARKET, BY APPLICATION 2017 VS. 2022
  • FIGURE 11: ORTHOBIOLOGICS MARKET, BY END USER, 2017 VS. 2022
  • FIGURE 12: GEOGRAPHICAL SNAPSHOT OF THE ORTHOBIOLOGICS MARKET, 2017
  • FIGURE 13: RISING INCIDENCE OF MUSCULOSKELETAL DISEASES IS EXPECTED TO DRIVE GROWTH OF THE ORTHOBIOLOGICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 14: VISCOSUPPLEMENTATION PRODUCTS SEGMENT IS EXPECTED TO DOMINATE THE ORTHOBIOLOGICS MARKET IN 2022
  • FIGURE 15: INDIA AND CHINA ARE EXPECTED TO BE THE MOST LUCRATIVE MARKETS FOR ORTHOBIOLOGICS MANUFACTURERS
  • FIGURE 16: OSTEOARTHRITIS AND DEGENERATIVE ARTHRITIS SEGMENT IS EXPECTED TO DOMINATE THE MARKET IN 2017
  • FIGURE 17: HOSPITALS, ORTHOPEDIC CLINICS, AND AMBULATORY CARE CENTERS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: ORTHOBIOLOGICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19: NUMBER OF ROAD ACCIDENTS WORLDWIDE: 2010 VS. 2014
  • FIGURE 20: GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 VS. 2050
  • FIGURE 21: VISCOSUPPLEMENTATION PRODUCTS TO DOMINATE THE ORTHOBIOLOGICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 22: SPINAL FUSIONS FORM THE FASTEST-GROWING APPLICATION SEGMENT IN THE GLOBAL ORTHOBIOLOGICS MARKET
  • FIGURE 23: HOSPITALS, ORTHOPEDIC CLINICS, AND AMBULATORY CARE CENTERS TO FORM THE FASTEST-GROWING END-USER SEGMENT IN THE GLOBAL ORTHOBIOLOGICS MARKET
  • FIGURE 24: NORTH AMERICA: ORTHOBIOLOGICS MARKET SNAPSHOT
  • FIGURE 25: EUROPE: ORTHOBIOLOGICS MARKET SNAPSHOT
  • FIGURE 26: ASIA PACIFIC: ORTHOBIOLOGICS MARKET SNAPSHOT
  • FIGURE 27: ROW: ORTHOBIOLOGICS MARKET SNAPSHOT
  • FIGURE 28: JOHNSON & JOHNSON: COMPANY SNAPSHOT
  • FIGURE 29: MEDTRONIC PLC: COMPANY SNAPSHOT
  • FIGURE 30: STRYKER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 31: ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT
  • FIGURE 32: TERUMO CORPORATION: COMPANY SNAPSHOT 111  
  • FIGURE 33: GLOBUS MEDICAL, INC.: COMPANY SNAPSHOT
  • FIGURE 34: ORTHOFIX INTERNATIONAL N.V.: COMPANY SNAPSHOT
  • FIGURE 35: RTI SURGICAL: COMPANY SNAPSHOT
  • FIGURE 36: K2M GROUP HOLDINGS, INC.: COMPANY SNAPSHOT
  • FIGURE 37: KUROS BIOSCIENCES LTD.: COMPANY SNAPSHOT

영문목차

"The orthobiologics market projected to grow at a CAGR of 5.4%."

The global orthobiologics market is projected to reach USD 6.06 billion by 2022 from USD 4.66 billion in 2017, at a CAGR of 5.4%. Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high incidence of musculoskeletal disorders; and growing patient preference for minimally invasive procedures are driving the orthobiologics market. However, high cost pertaining to orthobiologics based treatment is the major factor restraining the market growth to a certain extent.

"The PRP segment is expected to grow at the highest rate during the forecast period."

The PRP market is expected to grow at the highest CAGR during the forecast period. The advantages of PRP (such as reduced hospital stay) over other products used in bone stimulation are expected to drive the growth of this market. Additionally, the increasing use of PRP in sports injuries and the growing number of clinical trials to expand the application areas of PRP are expected to support the growth of this market during the forecast period.

"The spinal fusion segment is expected to grow at the highest CAGR."

Based on applications, the orthobiologics market has been categorized into the following segments: fracture recovery, osteoarthritis & degenerative arthritis, spinal fusion, soft-tissue injuries, and maxillofacial & dental applications. Amongst these, the spinal fusion segment is expected to grow at highest CAGR during the forecast period owing to factors such as the rising number of spinal fusion procedures, increasing adoption of allografts & BMAC as part of adjuvant therapy during spinal fusion procedures, & extensive use of stem cells for bone regeneration and bone grafting procedures.

"Hospitals, orthopedic clinics, and ambulatory care centers are expected to be the fastest-growing segment."

On the basis of end user, the market is segmented into hospitals, orthopedic clinics, and ambulatory care centers; research & academic institutes; and dental clinics and facilities. The hospitals, orthopedic clinics, and ambulatory care centers segment is expected to grow at the highest rate during the forecast period. This can be attributed to the growing geriatric population (coupled with the increasing number of spinal fusion surgeries performed); road accident injuries and bone fractures; growing prevalence of spinal disorders; and growing awareness of products.

"Asia Pacific is expected to register the highest growth rate in the orthobiologics market."

Geographically, the orthobiologics market is segmented into North America, Europe, Asia Pacific, and RoW. The Asia Pacific market is expected to register the highest growth rate during the forecast period. The presence of a large geriatric and target patient population, high incidence of osteoarthritis and obesity, increasing government spending on healthcare, and improving healthcare infrastructure are some of the major factors driving the growth of the Asia Pacific orthobiologics market.

Breakdown of supply-side primary interviews:

  • By Company Type - Tier 1 - 25%, Tier 2 - 30% and Tier 3 - 45%
  • By Designation - - C-level - 26%, Director level - 30%, Others - 44%
  • By Region - North America - 34%, Europe - 26%, APAC - 23%, RoW - 17%

The major players in the market included are DePuy Synthes, Medtronic, Stryker, Zimmer Biomet, Harvest Technologies, and Globus Medical.

Research Coverage:

This report studies the orthobiologics market based on product, application, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends. The report forecasts the revenue of the market segments with respect to four main regions and respective countries.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis-industry trends, market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the orthobiologics market, and high-growth regions and their drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKETS COVERED
    • 1.3.1. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. RESEARCH LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. MARKET SIZE ESTIMATION METHODOLOGY
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. RESEARCH ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL ORTHOBIOLOGICS MARKET OVERVIEW
  • 4.2. GLOBAL ORTHOBIOLOGICS MARKET: BY PRODUCT (2017 VS. 2022)
  • 4.3. ORTHOBIOLOGICS MARKET: REGIONAL ANALYSIS (2017-2022)
  • 4.4. ORTHOBIOLOGICS MARKET: BY APPLICATION, 2017
  • 4.5. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY END USER

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. MARKET DRIVERS
      • 5.2.1.1. Increasing incidence of sports injuries and road accidents
      • 5.2.1.2. Increasing incidence of spinal diseases/disorders
      • 5.2.1.3. Rising geriatric and obese population
      • 5.2.1.4. Growing patient preference for minimally invasive procedures
    • 5.2.2. MARKET RESTRAINT
      • 5.2.2.1. High cost associated with orthobiologics-based treatments
    • 5.2.3. GROWTH OPPORTUNITIES
      • 5.2.3.1. Emerging markets
      • 5.2.3.2. Increasing use of PRP in other applications
    • 5.2.4. MARKET CHALLENGES
      • 5.2.4.1. Lawsuits filed against major market players affecting their brand value
      • 5.2.4.2. Side effects associated with BMP-based treatments
  • 5.3. KEY INDUSTRY TREND

6. ORTHOBIOLOGICS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. VISCOSUPPLEMENTATION PRODUCTS
  • 6.3. DEMINERALIZED BONE MATRICES
  • 6.4. SYNTHETIC ORTHOBIOLOGICS
  • 6.5. BONE MORPHOGENIC PROTEIN
  • 6.6. ALLOGRAFTS
  • 6.7. PLASMA-RICH PROTEIN
  • 6.8. BONE MARROW ASPIRATE CONCENTRATE

7. ORTHOBIOLOGICS MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. OSTEOARTHRITIS AND DEGENERATIVE ARTHRITIS
  • 7.3. SPINAL FUSION
  • 7.4. SOFT-TISSUE INJURIES
  • 7.5. FRACTURE RECOVERY
  • 7.6. MAXILLOFACIAL AND DENTAL APPLICATIONS

8. ORTHOBIOLOGICS MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. HOSPITALS, ORTHOPEDIC CLINICS, & AMBULATORY CARE CENTERS
  • 8.3. RESEARCH & ACADEMIC INSTITUTES
  • 8.4. DENTAL CLINICS AND FACILITIES

9. ORTHOBIOLOGICS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. FRANCE
    • 9.3.3. UK
    • 9.3.4. SPAIN
    • 9.3.5. ITALY
    • 9.3.6. REST OF EUROPE
  • 9.4. ASIA PACIFIC
    • 9.4.1. JAPAN
    • 9.4.2. CHINA
    • 9.4.3. INDIA
    • 9.4.4. REST OF ASIA PACIFIC
  • 9.5. REST OF THE WORLD

10. COMPETITIVE LANDSCAPE

  • 10.1. GLOBAL ORTHOBIOLOGICS MARKET RANKING, 2016

11. COMPANY PROFILES (Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*

  • 11.1. DEPUY SYNTHES (A SUBSIDIARY OF JOHNSON & JOHNSON)
  • 11.2. MEDTRONIC PLC.
  • 11.3. STRYKER CORPORATION
  • 11.4. ZIMMER BIOMET HOLDINGS, INC.
  • 11.5. HARVEST TECHNOLOGIES CORPORATION (A TERUMO BCT COMPANY)
  • 11.6. GLOBUS MEDICAL, INC.
  • 11.7. ORTHOFIX INTERNATIONAL N.V.
  • 11.8. RTI SURGICAL, INC.
  • 11.9. K2M GROUP HOLDINGS, INC.
  • 11.10. KUROS BIOSCIENCES LTD.
  • 11.11. BIOVENTUS LLC
  • 11.12. NUVASIVE, INC.
  • 11.13. SEASPINE HOLDINGS CORPORATION
  • 11.14. ARTHREX, INC.
  • 11.15. XTANT MEDICAL HOLDINGS, INC.

*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORTS
  • 12.6. AUTHOR DETAILS
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
BCC Research